Sabra Capital Surpluse vs Accounts Payable Analysis

SBRA Stock

USD 18.71 0.83 4.25%

Sabra Healthcare financial indicator trend analysis is much more than just breaking down Sabra Healthcare REIT prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Sabra Healthcare REIT is a good investment. Please check the relationship between Sabra Healthcare Capital Surpluse and its Accounts Payable accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sabra Healthcare REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Capital Surpluse vs Accounts Payable

Capital Surpluse vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Sabra Healthcare REIT Capital Surpluse account and Accounts Payable. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Sabra Healthcare's Capital Surpluse and Accounts Payable is 0.91. Overlapping area represents the amount of variation of Capital Surpluse that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Sabra Healthcare REIT, assuming nothing else is changed. The correlation between historical values of Sabra Healthcare's Capital Surpluse and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Surpluse of Sabra Healthcare REIT are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Capital Surpluse i.e., Sabra Healthcare's Capital Surpluse and Accounts Payable go up and down completely randomly.

Correlation Coefficient

0.91

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Capital Surpluse

Accounts Payable

An accounting item on the balance sheet that represents Sabra Healthcare obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Sabra Healthcare REIT are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most indicators from Sabra Healthcare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Sabra Healthcare REIT current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sabra Healthcare REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

The current year's Sales General And Administrative To Revenue is expected to grow to 0.11, whereas Selling General Administrative is forecasted to decline to about 29.5 M.

	2021	2022	2023	2024 (projected)
Gross Profit	428.3M	462.2M	277.5M	326.2M
Total Revenue	569.5M	624.8M	655.8M	404.9M

Gross Profit Total Revenue

Sabra Healthcare fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock	Retained Earnings Total Equity
Total Assets		0.95	-0.68	0.65	0.99	0.44	0.48	0.98	-0.56	0.91	0.44	1.0	0.99	0.41	0.45	0.44	0.86	0.87	0.43	0.98	0.93	0.99	0.39	0.74	0.94	-0.61
Short Long Term Debt Total	0.95		-0.75	0.63	0.95	0.39	0.61	0.91	-0.55	0.94	0.41	0.94	0.94	0.56	0.56	0.41	0.82	0.85	0.53	0.91	0.93	0.92	0.33	0.73	0.91	-0.62
Other Current Liab	-0.68	-0.75		-0.03	-0.68	-0.51	-0.06	-0.63	-0.06	-0.64	-0.4	-0.68	-0.69	-0.11	0.03	-0.4	-0.33	-0.43	-0.3	-0.68	-0.6	-0.67	-0.14	-0.5	-0.52	0.04
Total Current Liabilities	0.65	0.63	-0.03		0.67	0.04	0.76	0.63	-0.94	0.63	0.13	0.65	0.64	0.81	0.84	0.13	0.94	0.77	0.28	0.59	0.74	0.61	0.37	0.49	0.77	-0.9
Total Stockholder Equity	0.99	0.95	-0.68	0.67		0.38	0.54	0.96	-0.59	0.94	0.39	0.99	0.99	0.46	0.49	0.39	0.88	0.9	0.45	0.95	0.97	0.96	0.38	0.7	0.96	-0.65
Other Liab	0.44	0.39	-0.51	0.04	0.38		-0.17	0.49	0.07	0.26	0.36	0.44	0.45	-0.08	-0.18	0.36	0.19	0.16	-0.09	0.52	0.24	0.5	0.14	0.35	0.23	0.06
Property Plant And Equipment Net	0.48	0.61	-0.06	0.76	0.54	-0.17		0.43	-0.84	0.69	-0.06	0.48	0.47	0.84	0.98	-0.06	0.73	0.76	0.6	0.37	0.7	0.4	0.26	0.4	0.7	-0.87
Net Debt	0.98	0.91	-0.63	0.63	0.96	0.49	0.43		-0.55	0.86	0.4	0.98	0.98	0.34	0.4	0.4	0.83	0.85	0.41	0.99	0.88	0.99	0.42	0.74	0.91	-0.6
Retained Earnings	-0.56	-0.55	-0.06	-0.94	-0.59	0.07	-0.84	-0.55		-0.61	0.03	-0.55	-0.55	-0.75	-0.89	0.03	-0.88	-0.79	-0.48	-0.48	-0.7	-0.51	-0.38	-0.49	-0.74	0.98
Accounts Payable	0.91	0.94	-0.64	0.63	0.94	0.26	0.69	0.86	-0.61		0.28	0.91	0.91	0.52	0.63	0.28	0.84	0.9	0.63	0.85	0.95	0.85	0.28	0.65	0.94	-0.71
Cash	0.44	0.41	-0.4	0.13	0.39	0.36	-0.06	0.4	0.03	0.28		0.41	0.4	-0.02	-0.04	1.0	0.23	0.05	0.11	0.52	0.26	0.5	-0.03	0.66	0.26	0.03
Non Current Assets Total	1.0	0.94	-0.68	0.65	0.99	0.44	0.48	0.98	-0.55	0.91	0.41		0.99	0.41	0.44	0.41	0.86	0.88	0.4	0.98	0.93	0.98	0.38	0.69	0.94	-0.6
Non Currrent Assets Other	0.99	0.94	-0.69	0.64	0.99	0.45	0.47	0.98	-0.55	0.91	0.4	0.99		0.41	0.44	0.4	0.85	0.87	0.42	0.98	0.93	0.98	0.45	0.73	0.93	-0.61
Other Assets	0.41	0.56	-0.11	0.81	0.46	-0.08	0.84	0.34	-0.75	0.52	-0.02	0.41	0.41		0.87	-0.02	0.7	0.61	0.21	0.31	0.6	0.34	0.27	0.29	0.57	-0.71
Long Term Debt	0.45	0.56	0.03	0.84	0.49	-0.18	0.98	0.4	-0.89	0.63	-0.04	0.44	0.44	0.87		-0.04	0.76	0.71	0.54	0.35	0.65	0.37	0.24	0.38	0.66	-0.9
Cash And Short Term Investments	0.44	0.41	-0.4	0.13	0.39	0.36	-0.06	0.4	0.03	0.28	1.0	0.41	0.4	-0.02	-0.04		0.23	0.05	0.11	0.52	0.26	0.5	-0.03	0.66	0.26	0.03
Common Stock Total Equity	0.86	0.82	-0.33	0.94	0.88	0.19	0.73	0.83	-0.88	0.84	0.23	0.86	0.85	0.7	0.76	0.23		0.91	0.44	0.8	0.91	0.82	0.39	0.63	0.93	-0.89
Common Stock Shares Outstanding	0.87	0.85	-0.43	0.77	0.9	0.16	0.76	0.85	-0.79	0.9	0.05	0.88	0.87	0.61	0.71	0.05	0.91		0.56	0.79	0.96	0.81	0.45	0.56	0.98	-0.84
Short Term Investments	0.43	0.53	-0.3	0.28	0.45	-0.09	0.6	0.41	-0.48	0.63	0.11	0.4	0.42	0.21	0.54	0.11	0.44	0.56		0.38	0.55	0.39	0.08	0.54	0.55	-0.61
Non Current Liabilities Total	0.98	0.91	-0.68	0.59	0.95	0.52	0.37	0.99	-0.48	0.85	0.52	0.98	0.98	0.31	0.35	0.52	0.8	0.79	0.38		0.86	1.0	0.38	0.76	0.88	-0.53
Other Stockholder Equity	0.93	0.93	-0.6	0.74	0.97	0.24	0.7	0.88	-0.7	0.95	0.26	0.93	0.93	0.6	0.65	0.26	0.91	0.96	0.55	0.86		0.87	0.4	0.66	0.99	-0.77
Total Liab	0.99	0.92	-0.67	0.61	0.96	0.5	0.4	0.99	-0.51	0.85	0.5	0.98	0.98	0.34	0.37	0.5	0.82	0.81	0.39	1.0	0.87		0.39	0.77	0.89	-0.55
Property Plant And Equipment Gross	0.39	0.33	-0.14	0.37	0.38	0.14	0.26	0.42	-0.38	0.28	-0.03	0.38	0.45	0.27	0.24	-0.03	0.39	0.45	0.08	0.38	0.4	0.39		0.4	0.43	-0.36
Total Current Assets	0.74	0.73	-0.5	0.49	0.7	0.35	0.4	0.74	-0.49	0.65	0.66	0.69	0.73	0.29	0.38	0.66	0.63	0.56	0.54	0.76	0.66	0.77	0.4		0.68	-0.53
Common Stock	0.94	0.91	-0.52	0.77	0.96	0.23	0.7	0.91	-0.74	0.94	0.26	0.94	0.93	0.57	0.66	0.26	0.93	0.98	0.55	0.88	0.99	0.89	0.43	0.68		-0.8
Retained Earnings Total Equity	-0.61	-0.62	0.04	-0.9	-0.65	0.06	-0.87	-0.6	0.98	-0.71	0.03	-0.6	-0.61	-0.71	-0.9	0.03	-0.89	-0.84	-0.61	-0.53	-0.77	-0.55	-0.36	-0.53	-0.8

Click cells to compare fundamentals

Sabra Healthcare Account Relationship Matchups

Sabra Healthcare fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	6.1B	6.0B	6.0B	5.7B	5.4B	4.2B
Short Long Term Debt Total	2.4B	3.7B	4.2B	2.7B	2.4B	2.2B
Other Current Liab	(1.2B)	(1.2B)	(1.8B)	(197.0M)	34.8M	36.5M
Total Current Liabilities	108.8M	146.3M	143.0M	142.3M	231.4M	243.0M
Total Stockholder Equity	3.5B	3.4B	3.4B	3.1B	2.8B	2.1B
Net Debt	2.4B	2.3B	2.3B	2.7B	2.4B	1.9B
Retained Earnings	(573.3M)	(716.2M)	(1.1B)	(1.5B)	(1.7B)	(1.6B)
Accounts Payable	108.8M	146.3M	143.0M	142.3M	73.8M	76.6M
Cash	39.1M	59.1M	112.0M	49.3M	46.7M	87.0M
Non Current Assets Total	5.8B	5.7B	5.3B	5.1B	4.8B	3.8B
Non Currrent Assets Other	5.3B	5.3B	5.2B	5.0B	4.6B	3.5B
Other Assets	19M	5.7B	5.3B	398.9M	5.2B	5.4B
Long Term Debt	113.1M	2.4B	2.4B	2.3B	2.3B	2.4B
Cash And Short Term Investments	39.1M	59.1M	112.0M	49.3M	46.7M	87.0M
Common Stock Total Equity	2.1M	2.1M	2.3M	2.3M	2.7M	2.8M
Common Stock Shares Outstanding	188.1M	207.3M	219.1M	230.9M	232.8M	131.1M
Liabilities And Stockholders Equity	6.1B	6.0B	6.0B	5.7B	5.4B	4.2B
Non Current Liabilities Total	2.5B	2.4B	2.4B	2.5B	2.4B	1.9B
Other Stockholder Equity	4.6B	4.9B	5.6B	4.5B	4.5B	2.9B
Total Liab	2.6B	2.6B	2.6B	2.7B	2.6B	2.0B
Total Current Assets	307.0M	329.0M	653.1M	613.2M	543.3M	413.9M
Accumulated Other Comprehensive Income	(12.4M)	(39.9M)	(10.0M)	19.1M	963K	1.0M
Common Stock	2.1M	2.1M	2.3M	2.3M	2.3M	1.4M
Good Will	167.1M	131.1M	101.5M	82.8M	95.2M	53.1M
Retained Earnings Total Equity	(573.3M)	(716.2M)	(1.1B)	(1.5B)	(1.3B)	(1.2B)
Other Current Assets	(49.1M)	(65.5M)	(115.9M)	(406.8M)	(46.7M)	(44.4M)
Intangible Assets	101.5M	82.8M	54.1M	40.1M	30.9M	59.5M
Property Plant Equipment	5.3B	5.3B	5.2B	5.0B	5.7B	3.7B
Net Tangible Assets	3.5B	3.4B	3.3B	3.0B	3.5B	2.4B
Net Receivables	257.8M	263.5M	537.2M	559.3M	496.6M	323.0M
Long Term Debt Total	113.1M	2.4B	2.4B	2.3B	2.7B	2.8B
Capital Surpluse	4.1B	4.2B	4.5B	4.5B	5.2B	2.9B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

F	Ford Motor
GM	General Motors
MSFT	Microsoft

When determining whether Sabra Healthcare REIT offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sabra Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sabra Healthcare Reit Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sabra Healthcare Reit Stock:

How To Invest In Sabra

Details

Is Sabra Stock a good investment?

Details

What is Sabra Healthcare's Net Worth?

Details

Largest Diversified REITs Companies

View

Largest Equity Real Estate Investment Trusts (REITs) Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sabra Healthcare REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sabra Healthcare. If investors know Sabra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sabra Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.111

Dividend Share

1.2

Earnings Share

0.41

Revenue Per Share

2.943

Quarterly Revenue Growth

0.107

The market value of Sabra Healthcare REIT is measured differently than its book value, which is the value of Sabra that is recorded on the company's balance sheet. Investors also form their own opinion of Sabra Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Sabra Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sabra Healthcare's market value can be influenced by many factors that don't directly affect Sabra Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Sabra Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sabra Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sabra Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Sabra Capital Surpluse vs Accounts Payable Analysis

Capital Surpluse vs Accounts Payable

Capital Surpluse vs Accounts Payable Correlation Analysis

Correlation Coefficient

Capital Surpluse

Accounts Payable

Sabra Healthcare fundamental ratios Correlations

Sabra Healthcare Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Sabra Healthcare fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Total Liab	+ 1.0	Non Current Liabilities Total
Total Stockholder Equity	+ 0.99	Total Assets
Non Currrent Assets Other	+ 0.99	Total Assets
Total Liab	+ 0.99	Total Assets

Retained Earnings	- 0.94	Total Current Liabilities
Retained Earnings Total Equity	- 0.9	Long Term Debt
Retained Earnings Total Equity	- 0.9	Total Current Liabilities
Retained Earnings Total Equity	- 0.89	Common Stock Total Equity
Long Term Debt	- 0.89	Retained Earnings
Common Stock Total Equity	- 0.88	Retained Earnings